about
Contact-facilitated drug delivery with Sn2 lipase labile prodrugs optimize targeted lipid nanoparticle drug deliveryA novel mouse model for multiple myeloma (MOPC315.BM) that allows noninvasive spatiotemporal detection of osteolytic diseaseMithramycin exerts an anti-myeloma effect and displays anti-angiogenic effects through up-regulation of anti-angiogenic factorsMyeloma plasma cells alter the bone marrow microenvironment by stimulating the proliferation of mesenchymal stromal cells.SAMSN1 is a tumor suppressor gene in multiple myeloma.Soluble rank ligand produced by myeloma cells causes generalised bone loss in multiple myelomaTreatment of multiple myeloma with adoptively transferred chimeric NKG2D receptor-expressing T cellsMathematical model for radial expansion and conflation of intratumoral infectious centers predicts curative oncolytic virotherapy parameters.[(89)Zr]oxinate4 for long-term in vivo cell tracking by positron emission tomography.Multifunctional role of matrix metalloproteinases in multiple myeloma: a study in the 5T2MM mouse model.Risk of multiple myeloma in rheumatoid arthritis: a meta-analysis of case-control and cohort studies.Stem cell-based therapies in ischemic heart diseases: a focus on aspects of microcirculation and inflammation.Primary neoplasms of bones in mice: retrospective study and review of literatureGr-1+CD11b+ myeloid-derived suppressor cells: formidable partners in tumor metastasisHost-derived adiponectin is tumor-suppressive and a novel therapeutic target for multiple myeloma and the associated bone disease.Combining α-Radioimmunotherapy and Adoptive T Cell Therapy to Potentiate Tumor Destruction.Detection of myeloma in skeleton of mice by whole-body optical fluorescence imaging.An in vivo model of human multidrug-resistant multiple myeloma in SCID miceErythropoietin induces tumor regression and antitumor immune responses in murine myeloma modelsThe 5T mouse multiple myeloma model: absence of c-myc oncogene rearrangement in early transplant generations.A model of multiple myeloma: culture of 5T33 murine myeloma cells and evaluation of tumorigenicity in the C57BL/KaLwRij mousePTTG1 expression is associated with hyperproliferative disease and poor prognosis in multiple myeloma.Anaplastic plasmacytomas: relationships to normal memory B cells and plasma cell neoplasms of immunodeficient and autoimmune mice.Single-Dose Anti-CD138 Radioimmunotherapy: Bismuth-213 is More Efficient than Lutetium-177 for Treatment of Multiple Myeloma in a Preclinical ModelOrgan involvement and phenotypic adhesion profile of 5T2 and 5T33 myeloma cells in the C57BL/KaLwRij mouse.Preclinical animal models of multiple myelomaMurine 5T multiple myeloma cells induce angiogenesis in vitro and in vivo.Perfusion Pressure Is a Critical Determinant of the Intratumoral Extravasation of Oncolytic VirusesTherapeutic antitumor efficacy of anti-CD137 agonistic monoclonal antibody in mouse models of myelomaBone marrow stromal cells create a permissive microenvironment for myeloma development: a new stromal role for Wnt inhibitor Dkk1.A murine model of myeloma that allows genetic manipulation of the host microenvironment.Programmed death receptor-1/programmed death receptor ligand-1 blockade after transient lymphodepletion to treat myeloma.Efficacy and mechanism-of-action of a novel superagonist interleukin-15: interleukin-15 receptor αSu/Fc fusion complex in syngeneic murine models of multiple myelomaUnderstanding the hypoxic niche of multiple myeloma: therapeutic implications and contributions of mouse models.Immune recovery after cyclophosphamide treatment in multiple myeloma: implication for maintenance immunotherapy.Antitumour and antiangiogenic effects of Aplidin in the 5TMM syngeneic models of multiple myelomaPEGylation of vesicular stomatitis virus extends virus persistence in blood circulation of passively immunized mice.Correlation of high-resolution X-ray micro-computed tomography with bioluminescence imaging of multiple myeloma growth in a xenograft mouse model.Follow-up of bone lesions in an experimental multiple myeloma mouse model: description of an in vivo technique using radiography dedicated for mammography.Effects of the glucolipid synthase inhibitor, P4, on functional and phenotypic parameters of murine myeloma cells.
P2860
Q26795703-4A41A6DD-E113-419A-8659-9C571DF6DFF4Q27329429-0C8D2E0F-5D36-4119-B968-550A29721C82Q28487743-434A5F2E-1ACD-42C6-A84C-7BA8F8D66587Q33558170-59EBB2B1-2094-4793-AF17-3BFA18C5B865Q34347229-11FA8BDA-3430-4BB0-AA43-2EC50F229B7FQ34404651-5765B74E-7A77-4F8C-90B3-FF4C506A63D9Q34985537-A150874B-1BEB-44B2-8639-349CACA4AD26Q34989252-980232DE-CB32-4386-AAEC-9A0397B23927Q35043558-CD0F0AAA-0A67-450B-9442-C9FF8C60A3ECQ35103092-16EAF648-051D-482D-BCC2-3A330CB87363Q35120199-D583218E-997E-4761-B795-255B695ABADAQ35128063-5B814C42-5D65-49F4-851E-FF67AC38A76DQ35151483-B1748F1D-2139-4A02-9355-97B492F4AD9AQ35156109-66E86680-6EF2-42B2-A30A-EE49950AB52BQ35585973-129B7F57-16F0-4C3F-BCD2-4A88A36A211EQ35670632-CC66337C-F8F7-4BD0-B95D-36F1D238FE06Q35787070-2436795D-C536-4F49-9EB4-B31F77BD4974Q35832500-30A713AE-B3D9-4891-96D1-B843232F2086Q35867538-4D90A3AA-2B2B-4283-972C-C6DE26A16FBBQ35981847-0644FF7D-8637-44CA-AFE3-8D53BA5C293AQ35994671-C0390E08-FB9A-4A36-B192-344FB9661F8FQ36126937-B7B2BBB2-FE76-4B43-9A64-5F2AE59AC585Q36154339-EB57E059-09A3-4C6C-97B8-8A9FE5202137Q36245624-2F2D046C-2B82-46E1-9EB7-860A24F1DE6CQ36430970-4BD8D9CF-D682-425E-906B-EB45AE385DE3Q36561366-AB80CF97-128D-4034-8592-41A5246D5B3BQ36644266-D0E09957-7EC4-41D1-AADF-9D01EF07095EQ36756897-AF639D2D-BA46-4D7E-9204-15CBF71FD857Q36975064-26B911CE-AA72-45E4-9370-DC65348CC4BAQ37178131-D16ABFA1-D214-47C1-ADB0-EBC94C4D35F1Q37418589-E1CCC062-A7D4-4CA4-9081-A63B1A5B28A3Q37478912-A29D4BE6-E1A5-400C-832D-439A2736B569Q37557639-BCB4296C-3AFB-4E7C-8D11-6437AA32CD1FQ38056889-38CA8E1F-8648-45E5-A39F-78812FB2A92FQ38729516-C6C352A4-0D12-40B1-9AAF-3B3115B13356Q39638460-13A22B5C-250B-435C-86D4-8960F6226503Q39788723-38F1E917-7F03-4E7B-A0A3-65AE5D3EB793Q39789556-DAFE3F52-E2DC-4833-9D50-F0FD174A5073Q39995568-E6E5BBC2-6896-44A8-B8DA-2714470A959DQ41788470-8BEC9030-6700-4DDD-B3E7-BE2F7359A702
P2860
description
1988 nî lūn-bûn
@nan
1988年の論文
@ja
1988年学术文章
@wuu
1988年学术文章
@zh-cn
1988年学术文章
@zh-hans
1988年学术文章
@zh-my
1988年学术文章
@zh-sg
1988年學術文章
@yue
1988年學術文章
@zh
1988年學術文章
@zh-hant
name
Animal model of human disease. Multiple myeloma.
@en
Animal model of human disease. Multiple myeloma.
@nl
type
label
Animal model of human disease. Multiple myeloma.
@en
Animal model of human disease. Multiple myeloma.
@nl
prefLabel
Animal model of human disease. Multiple myeloma.
@en
Animal model of human disease. Multiple myeloma.
@nl
P2093
P2860
P1476
Animal model of human disease. Multiple myeloma
@en
P2093
A M de Leeuw
J W Croese
M H Van den Enden-Vieveen
P2860
P304
P407
P577
1988-09-01T00:00:00Z